These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38536547)
1. Increased risk of nephrolithiasis: an emerging issue in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Chiarito M; Lattanzio C; D'Ascanio V; Capalbo D; Cavarzere P; Grandone A; Aiello F; Pepe G; Wasniewska M; Zoller T; Salerno M; Faienza MF Endocrine; 2024 May; 84(2):727-734. PubMed ID: 38536547 [TBL] [Abstract][Full Text] [Related]
2. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia]. Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236 [TBL] [Abstract][Full Text] [Related]
3. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma. Ozgen AG; Bayraktar F; Yilmaz C Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia. Ng SM; Stepien KM; Krishan A Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901 [TBL] [Abstract][Full Text] [Related]
5. The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia. Ljubicic ML; Madsen A; Juul A; Almstrup K; Johannsen TH Front Endocrinol (Lausanne); 2021; 12():652888. PubMed ID: 34531821 [TBL] [Abstract][Full Text] [Related]
6. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia. Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212 [TBL] [Abstract][Full Text] [Related]
7. 17-Hydroxyprogesterone in children, adolescents and adults. Honour JW Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560 [TBL] [Abstract][Full Text] [Related]
9. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056 [TBL] [Abstract][Full Text] [Related]
10. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing. Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening. Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195 [TBL] [Abstract][Full Text] [Related]
12. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche. Granoff AB; Chasalow FI; Blethen SL J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895 [TBL] [Abstract][Full Text] [Related]
13. Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Kyritsi EM; Koltsida G; Farakla I; Papanikolaou A; Critselis E; Mantzou E; Zoumakis E; Kolaitis G; Chrousos GP; Charmandari E Hormones (Athens); 2017 Jan; 16(1):42-53. PubMed ID: 28500827 [TBL] [Abstract][Full Text] [Related]
14. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia. Çakir ED; Mutlu FS; Eren E; Paşa AO; Sağlam H; Tarim O J Clin Res Pediatr Endocrinol; 2012 Jun; 4(2):94-100. PubMed ID: 22672867 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era. Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839 [TBL] [Abstract][Full Text] [Related]
16. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OHD) in adult males: Clinical presentation, hormone function and the detection of adrenal and testicular adrenal rest tumors (TARTs). San Martín P; Eugenio Russmann ML; Mendeluk G; Fierro MF; Marino R; Pardes E Endocrinol Diabetes Nutr (Engl Ed); 2021 Apr; 68(4):227-235. PubMed ID: 34266634 [TBL] [Abstract][Full Text] [Related]
17. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244 [TBL] [Abstract][Full Text] [Related]
18. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency. Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498 [TBL] [Abstract][Full Text] [Related]
19. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Völkl TM; Simm D; Körner A; Kiess W; Kratzsch J; Dörr HG Acta Paediatr; 2009 May; 98(5):885-91. PubMed ID: 19236311 [TBL] [Abstract][Full Text] [Related]
20. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency]. Shibata Y Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]